Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 6/20 | 0.37 |
| ▸ | PRMT6 | Q96LA8 | 6/20 | 0.37 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.37 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | HRH2 | P25021 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8724935 | 0.78 | CARM1 (0.41) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL1111914 | 0.75 | PABPC1 (0.47) | CARM1PRMT6PRMT1PRMT8GNAI3 | |
| SCHEMBL2280536 | 0.74 | CARM1 (0.41) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL3412663 | 0.74 | KDM1A (0.44) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL14173452 | 0.74 | ALOX15 (0.50) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL5789303 | 0.73 | CARM1 (0.34) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL1268695 | 0.72 | GNAO1 (0.51) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL963156 | 0.71 | KDM1A (0.49) | CARM1PRMT6PRMT1PRMT8HRH3 | |
| SCHEMBL20648632 | 0.71 | GNAO1 (0.58) | GNAI3GNAO1GNAI1 | |
| SCHEMBL22878312 | 0.71 | GNAI3 (0.39) | CARM1PRMT6PRMT1PRMT8HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475277-B1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-10-20 | — | — | EP | disclosed |